← Back to Search

Procedure

Axillary lymphadenetomy alone for Lymphedema

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 yr
Awards & highlights

Study Summary

This trial will test a new surgery to see if it can reduce the risk of developing lymphedema, a condition caused by disrupted lymphatic system.

Eligible Conditions
  • Lymphedema

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 yr
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 yr for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bioiimpedance spectroscopy
Limb Volume
Lymphatic flow pattern of whole limb
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group AExperimental Treatment1 Intervention
Group A will under axillary lymphadenectomy alone
Group II: Group BActive Control1 Intervention
Group B will undergo axillary lymphadenectomy with immediate lymphatic reconstruction (LYMPHA) using reverse mapping using the SPY System.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,928 Total Patients Enrolled
13 Trials studying Lymphedema
6,492 Patients Enrolled for Lymphedema

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for individuals to join this experiment?

"Affirmative. The clinical trial registry on clinicaltrials.gov attests that recruitment for this medical study commenced on September 10th 2021 and the last update was made on June 20th 2022. This research endeavour is looking to enlist 80 participants from a single location."

Answered by AI

Does this research encompass people of advanced age?

"This clinical trial's entry requirements state that eligible applicants should be aged 18-75. For those outside of this age range, there are two trials for younger patients and a 76th study for adults over 65 years old."

Answered by AI

How many participants are being welcomed into this clinical investigation?

"Affirmative. Clinicaltrials.gov documents indicate that this investigation is currently recruiting patients, having been initially posted on September 10th 2021 and last amended June 20th 2022. 80 participants must be acquired from 1 hospital centre to meet the trial's requirements."

Answered by AI

To which population is enrollment in this trial open?

"This research is seeking 80 individuals that suffer from lymphedema and are between 18 - 75 years old. The selection process has already begun."

Answered by AI

Who else is applying?

What state do they live in?
Oregon
Illinois
How old are they?
18 - 65
What site did they apply to?
Stanford Cancer Institute
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
~24 spots leftby Jun 2025